Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulla Derhaschnig

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Thrombosis and Haemostasis|June 3, 2020
Differential Osteoprotegerin Kinetics after Stimulation with Desmopressin and Lipopolysaccharides In VivoNina Buchtele, Katarina D Kovacevic, Christine Brostjan, et al.
Scientific Reports|September 29, 2025
A randomized placebo-controlled trial in healthy volunteers examining the effects of acetaminophen and NO-acetaminophen NCX 701 in human endotoxemiaSophie Brunner-Ziegler, Moritz Staudacher, Christian Schörgenhofer, et al.
Scientific Reports|July 9, 2020
The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxinKatarina D Kovacevic, Nina Buchtele, Christian Schoergenhofer, et al.
Clinical Science (London, England : 1979)|January 28, 2003
Levels of adhesion molecules do not decrease after 3 months of statin therapy in moderate hypercholesterolaemiaBernd Jilma, Christian Joukhadar, Ulla Derhaschnig, et al.
Scientific Reports|August 2, 2019
Defibrotide enhances fibrinolysis in human endotoxemia - a randomized, double blind, crossover trial in healthy volunteersChristian Schoergenhofer, Nina Buchtele, Georg Gelbenegger, et al.
Thrombosis and Haemostasis|June 5, 2018
Can Sequential Coagulation Monitoring Predict Major Haemorrhage in Extremely Low Birth Weight Infants?Margarita Thanhaeuser, Christoph Binder, Ulla Derhaschnig, et al.
Critical Care Medicine|October 24, 2002
Angiotensin converting enzyme DD genotype is associated with hypertensive crisisGere Sunder-Plassmann, Harald Kittler, Corinna Eberle, et al.
Research and Practice in Thrombosis and Haemostasis|September 13, 2024
Pharmacokinetics and pharmacodynamics of low doses of recombinant tissue plasminogen activator to establish a model for biosimilarity comparisonsUlla Derhaschnig, Nina Buchtele, Margarete M Steiner, et al.
Journal of the American College of Cardiology|December 10, 2013
Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trialEva-Luise Hobl, Thomas Stimpfl, Josef Ebner, et al.
Transfusion|January 17, 2013
Recovery, safety, and tolerability of a solvent/detergent-treated and prion-safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteersPetra Jilma-Stohlawetz, Friedrich W Kursten, Michaela Horvath, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Thrombosis and Haemostasis|June 3, 2020
Differential Osteoprotegerin Kinetics after Stimulation with Desmopressin and Lipopolysaccharides In VivoNina Buchtele, Katarina D Kovacevic, Christine Brostjan, et al.
Scientific Reports|September 29, 2025
A randomized placebo-controlled trial in healthy volunteers examining the effects of acetaminophen and NO-acetaminophen NCX 701 in human endotoxemiaSophie Brunner-Ziegler, Moritz Staudacher, Christian Schörgenhofer, et al.
Scientific Reports|July 9, 2020
The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxinKatarina D Kovacevic, Nina Buchtele, Christian Schoergenhofer, et al.
Clinical Science (London, England : 1979)|January 28, 2003
Levels of adhesion molecules do not decrease after 3 months of statin therapy in moderate hypercholesterolaemiaBernd Jilma, Christian Joukhadar, Ulla Derhaschnig, et al.
Scientific Reports|August 2, 2019
Defibrotide enhances fibrinolysis in human endotoxemia - a randomized, double blind, crossover trial in healthy volunteersChristian Schoergenhofer, Nina Buchtele, Georg Gelbenegger, et al.
Thrombosis and Haemostasis|June 5, 2018
Can Sequential Coagulation Monitoring Predict Major Haemorrhage in Extremely Low Birth Weight Infants?Margarita Thanhaeuser, Christoph Binder, Ulla Derhaschnig, et al.
Critical Care Medicine|October 24, 2002
Angiotensin converting enzyme DD genotype is associated with hypertensive crisisGere Sunder-Plassmann, Harald Kittler, Corinna Eberle, et al.
Research and Practice in Thrombosis and Haemostasis|September 13, 2024
Pharmacokinetics and pharmacodynamics of low doses of recombinant tissue plasminogen activator to establish a model for biosimilarity comparisonsUlla Derhaschnig, Nina Buchtele, Margarete M Steiner, et al.
Journal of the American College of Cardiology|December 10, 2013
Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trialEva-Luise Hobl, Thomas Stimpfl, Josef Ebner, et al.
Transfusion|January 17, 2013
Recovery, safety, and tolerability of a solvent/detergent-treated and prion-safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteersPetra Jilma-Stohlawetz, Friedrich W Kursten, Michaela Horvath, et al.
Pageof 6